RISTIĆ, Lidija; RANČIĆ, Milan; RADOVIĆ, Milan
November 2010
Medicinski Pregled / Medical Review;2010, Vol. 63 Issue 11/12, p811
Academic Journal
No abstract available.


Related Articles

  • New Anti-Tuberculosis Drugs: Strategies, Sources and New Molecules. Palomino, Juan Carlos; Ramos, Daniela Fernandes; Da Silva, Pedro Almeida // Current Medicinal Chemistry;May2009, Vol. 16 Issue 15, p1898 

    Tuberculosis is still a major health problem worldwide. Although treatment regimens currently available can cure almost all tuberculosis drug susceptible cases, problems such as the length of treatment, the need for multidrug therapy, the emergence of drug resistance, HIV co-infection and...

  • Bedaquiline: A novel drug to combat multiple drug-resistant tuberculosis. Goel, Divya // Journal of Pharmacology & Pharmacotherapeutics;Jan-Mar2014, Vol. 5 Issue 1, p76 

    Tuberculosis (TB) is among the most common infectious diseases and continues as a major global health problem. The scenario is worsened by the emergence and spread of multiple drug-resistant tuberculosis (MDR-TB) and extensive drug-resistant tuberculosis (XDR-TB). Cure rates are high for drug...

  • The DprE1 enzyme, one of the most vulnerable targets of Mycobacterium tuberculosis. Riccardi, Giovanna; Pasca, Maria; Chiarelli, Laurent; Manina, Giulia; Mattevi, Andrea; Binda, Claudia // Applied Microbiology & Biotechnology;Oct2013, Vol. 97 Issue 20, p8841 

    The re-emergence of tuberculosis in recent years led the World Health Organization (WHO) to launch the Stop TB Strategy program. Beside repurposing the existing drugs and exploring novel molecular combinations, an essential step to face the burden of tuberculosis will be to develop new drugs by...

  • Assessment of extensively drug resistant tuberculosis by studying the drug sensitivity pattern in north Indian region. Sharma, Narotam; Sachan, Suneel Kumar; Bushan, Indu; Rai, Rinky; Shukla, Aayushi; Nehra, Aanchal; Yadav, Smrati; Nautiyal, Renu; Nautiyal, Satish C.; Singh, R. K. // Journal of Microbiology & Biotechnology Research;2014, Vol. 4 Issue 2, p31 

    Extensively drug-resistant tuberculosis (XDR-TB) is a form of TB caused by bacteria that are resistant to the most effective anti-TB drugs. The present study was carried out to demonstrate XDR prevalence in North Indian region. Out of 423 Mycobacterium tuberculosis cases, 166 had enough drug...

  • In vitro effect of fluoroquinolones against Mycobacterium tuberculosis isolates from Agra & Kanpur region of north India. Singh, Mradula; Chauhan, D. S.; Gupta, Pushpa; Das, R.; Srivastava, R. K.; Upadhyay, Prashant; Singh, Pushpendra; Srivastava, K.; Faujdar, Jaya; Jaudaun, G. P. S.; Yadav, V. S.; Sharma, V. D.; Venkatesan, K.; Sachan, S.; Sachan, P.; Katoch, K.; Katoch, V. M. // Indian Journal of Medical Research;May2009, Vol. 129 Issue 5, p542 

    Background & objectives: Fluoroquinolones (FQs) are important drugs used for treatment of drug resistant tuberculosis and are also now being considered as first line drugs to shorten the duration of treatment of tuberculosis (TB). In order to find out useful FQs for treatment of tuberculosis,...

  • Multidrug-resistant tuberculosis. Zager, Ellen M.; McNerney, Ruth // BMC Infectious Diseases;2008, Vol. 8 Issue 1, Special section p1 

    Background: With almost 9 million new cases each year, tuberculosis remains one of the most feared diseases on the planet. Led by the STOP-TB Partnership and WHO, recent efforts to combat the disease have made considerable progress in a number of countries. However, the emergence of mutated...

  • Ethionamide-induced gynecomastia. Dixit, Ramakant; George, Jacob; Sharma, Arun K.; chhabra, Naveen; Jangir, Suresh K.; Mishra, Vikas // Journal of Pharmacology & Pharmacotherapeutics;Apr2012, Vol. 3 Issue 2, p196 

    Gynecomastia is very rare during antituberculosis chemotherapy. We describe a 38-year-old male patient who developed a painful gynecomastia following second-line drug therapy for multidrug-resistant pulmonary tuberculosis. Gynecomastia disappeared after stopping the ethionamide. A published...

  • Antituberculosis Drug Resistance During Seven Years (2000-2006) in Federation of Bosnia and Herzegovina. Ustamujic, Aida; Zutic, Hasan; Dizdarevic, Zehra; Cukic, Vesna; Maglajlic, Jasminka; Abazovic, Jasmina // Materia Socio Medica;2009, Vol. 21 Issue 1, p43 

    The aim: To analyse present situation with drug-resistant tuberculosis in seven years period(2000-2006) in FB&H. To establish the frequency of cases with drug-resistant tuberculosis including numbers of cases with DST results by age and sex, total monoresistant, total multi-drug resistant and...

  • Multidrug-resistant tuberculosis emergence: a renewed challenge. Kritski, Afrânio Lineu // Jornal Brasileiro de Pneumologia;mar2010, Vol. 36 Issue 2, p157 

    The author reflects on the challenges in the control of multidrug-resistant tuberculosis (MDR-TB) in Brazil amid its global prevalence. He notes that there is a lack of laboratories for routine tests of MDR-TB. He says that Brazil is among the countries which lack measures for MDR-TB prevention...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics